Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-030179
Filing Date
2022-03-03
Accepted
2022-03-03 19:18:58
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm228319-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm228319-2_4seq1.xml 4 4095
  Complete submission text file 0001104659-22-030179.txt   5617
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG 1400E CAMBRIDGE MA 02139
Business Address
Nichols Andrew John (Reporting) CIK: 0001683749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 22711300